Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Hartford

Hartford Schroders US Small Cap Opportunities Fund Class I (SCUIX)

Ticker SCUIX · · Holdings as of Jul 31, 2026

Expense ratio
1.1%$110/yr per $10k
Net assets
$172.0Mall share classes
Holdings
82

Bottom line

Is SCUIX a good fund? The bottom line

SCUIX is the Class I share class of Hartford Schroders US Small Cap Opportunities Fund, an actively managed small-cap mutual fund from Hartford.

Its expense ratio is 1.1% — about $110 a year on every $10,000 invested, more expensive than 60% of small-cap funds we track.

With $172 million in net assets and 82 holdings, its largest position is ICU Medical Inc (2.7%) and the top 10 make up 20% of the portfolio.

What stands out

  • No front-end sales load

Updated Nov 19, 2026

What SCUIX invests in

The Fund seeks capital appreciation.

Under normal circumstances, the Fund invests primarily in equity securities of small capitalization companies. The Fund normally invests at least 80% of its assets in securities of small capitalization companies located in the United States. The Funds sub-adviser, Schroder Investment Management North America Inc. (SIMNA or the Sub-Adviser), uses bottom-up fundamental analysis to select securities. The Sub-Adviser seeks to identify securities that it believes offer the potential for capital appreciation based on: novel, superior, or niche products or services; sound operating characteristics; quality of management; an entrepreneurial management team; opportunities provided by mergers, divestitures, or new management; or other factors. In addition, the Sub-Adviser integrates financially material environmental, social and governance (ESG) characteristics (where available for an issuer)…

From the fund's prospectus (filed Feb 26, 2026).

What SCUIX costs

On a $10,000 investment, SCUIX's 1.1% expense ratio costs about $110 a year. The prospectus estimates $1,372 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full SCUIX fee table →

SCUIX top 10 holdings

#Holding% of fund
1ICU Medical Inc2.71%
2State Street Global Advisors2.59%
3Repligen Corp2.09%
4Hexcel Corp1.85%
5Reinsurance Group of America Inc1.83%
6US Physical Therapy Inc1.82%
7Cavco Industries Inc1.80%
8Perella Weinberg Partners1.78%
9Novanta Inc1.77%
10First BanCorp/Puerto Rico1.77%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 20% of the fund. See all top 25 holdings and asset mix →

Alternatives to SCUIX

More funds like SCUIX →

SCUIX FAQ

What is the expense ratio of SCUIX?
SCUIX's expense ratio is 1.1%, which works out to about $110 a year for every $10,000 invested. The prospectus estimates total costs of $1,372 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is SCUIX a good investment?
It depends on your goals, but the data points to: no front-end sales load. This is general information, not personalized advice.
What does SCUIX hold?
SCUIX's largest holdings are ICU Medical Inc (2.7%), State Street Global Advisors (2.6%), Repligen Corp (2.1%), Hexcel Corp (1.9%), Reinsurance Group of America Inc (1.8%). It holds 82 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
Does SCUIX have a sales load?
No. SCUIX has no front-end sales charge.
Who manages SCUIX?
SCUIX is offered by Hartford through Hartford Mutual Funds II, Inc.